The European Union Drugs Agency (EUDA) continues to monitor illicit drug production and precursor chemicals across Europe to improve understanding of how drug markets are evolving. Production within the European Union is primarily focused on synthetic stimulants, including amphetamine, MDMA, methamphetamine, and synthetic cathinones, while production methods are becoming increasingly flexible and adaptive.

The report also highlights the significant environmental and public safety risks associated with illicit drug production. Drug manufacturing can generate large amounts of hazardous chemical...